IRF5-IN-1 (compound C5) is an IRF5 pathway-specific inhibitor. IRF5-IN-1 significantly reduces IRF5 nuclear translocation without af fecting the activation of NF-κB p65. IRF5-IN-1 acts through SLC15A4 to selectively inhibit TLR7/8-induced IRF5 respon 1 * 5 mg
Catalog # MDEXHY-149652
Supplier: MEDCHEMEXPRESS
Frequently Bought Together